Advanced Biomed (ADVB) Income from Continuing Operations (2023 - 2026)

Advanced Biomed has disclosed Income from Continuing Operations across 4 years of filings, most recently posting 488942.0 for Q1 2026.

• Income from Continuing Operations for Q1 2026 came in at 488942.0, up 59.17% year-over-year; the trailing twelve-month figure through Mar 2026 was 4629472.0 (up 262.33% YoY), and the FY2025 annual result was 3258969.0, down 17.13% from the prior year.
• Income from Continuing Operations came in at 488942.0 for Q1 2026 at Advanced Biomed, down from 7002178.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 7002178.0 in Q4 2025 to a low of 1496863.0 in Q2 2025.
• The 4-year median for Income from Continuing Operations is 534218.0 (2024), against an average of 57593.7.
• Across the five-year window, Income from Continuing Operations plunged 298.7% in 2024 and jumped 1308.33% in 2025, its largest moves.
• Advanced Biomed's Income from Continuing Operations stood at 145345.0 in 2023, then tumbled by 298.7% to 579494.0 in 2024, then surged by 1308.33% to 7002178.0 in 2025, then tumbled by 106.98% to 488942.0 in 2026.
• The last three Income from Continuing Operations figures came in at 488942.0 (Q1 2026), 7002178.0 (Q4 2025), and 386901.0 (Q3 2025), per Business Quant data.